Nucleic Acid Amplification Testing Market 2022 Rising Demand for Probe Amplification Systems

According to Precision Business Insights (PBI) latest report, the global nucleic acid amplification testing market is expected to be worth USD 1,951.4 million in 2022, growing at a 9.4% CAGR from 2022 to 2028. Global Nucleic Acid Amplification Testing Market by Technique (Target amplification systems, Probe amplification systems, and Signal amplification) By Application (Infectious Diseases (Viruses, Bacteria, and Others) Cancer, Personalized Medicine, and Genetic and Mitochondrial Disorders) and Geography Forecast to 2028.

View the detailed report description here - https://precisionbusinessinsights.com/market-reports/nucleic-acid-amplification-testing-market/

Infectious Diseases Dominate the Nucleic Acid Amplification Testing Market:
Infectious Disease accounted for 63.7% of the market and is expected to grow at a CAGR of 9.2% between 2022 and 2028. The increasing prevalence of infectious bacterial and viral diseases across the globe drives the infectious segment in the market

The Asia Pacific Leads Nucleic Acid Amplification Testing Market:
The Asia Pacific holds a market share of 20.3% in the gene therapy market in the forecast period, and it is projected to grow at a CAGR of 10.2% in the coming years. The region's nucleic acid amplification testing market is being boosted by increasing demand for nucleic acid amplification testing in emerging economies such as India and China.

Strategic New Product Launches, Mergers, Acquisitions, and Agreements are the key strategies adopted by market players:
The Global Nucleic Acid Amplification Testing market further reveals that the key players increasingly adopting strategies such as the launch of newer products, frequent product approvals, and long-term alliances to improve market revenue share and gaining significant geographic presence across the region. For instance, In June 2020, Shionogi & Co., Ltd., a major participant in the Japanese pharmaceutical industry, formed a strategic partnership with Gunma University, Nihon University, and Tokyo Medical University to develop a modernized diagnostic method for infectious illness identification.

Request sample report at https://precisionbusinessinsights.com/request-sample?product_id=61939

Key player's profiles in the report are F. Hoffmann-La Roche, Becton, Dickinson and Company, Beckman Coulter, Abbott Laboratories, Illumina, Siemens Healthineers, bioMerieux, Novartis, and Bio-Rad Laboratories.

Contact:
Mr. Satya
Precision Business Insights | Toll Free: +1 866 598 1553
Email: sales@precisionbusinessinsights.com
Kemp House, 152 - 160 City Road, London EC1V 2NX
Web: https://precisionbusinessinsights.com/ | D U N S® Number: 85278174

About Precision Business Insights:
We are a market research company that strives to provide the highest quality market research insights. Our diverse market research experts are enthusiastic about market research and therefore produce high-quality research reports. We have over 500 clients with whom we have a good business partnership and capacity to provide in-depth research analysis for more than 30 countries. In addition to deliver more than 150 custom solutions, we already have accounts with the top five medical device manufacturers.

Precision Business Insights offers a variety of cost-effective and customized research services to meet particular research requirements. We are a leading research service provider because of our extensive database built by our experts and the services we provide.

This release was published on openPR.